RRx-001 Acts as a Dual Small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP-α on Monocytes/Macrophages-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RRx-001 Acts as a Dual Small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP-α on Monocytes/Macrophages

Published:2019-04 Issue:4 Volume:12 Page:626-632
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Cabrales Pedro

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Is CD47 an innate immune checkpoint for tumor evasion?;Liu;J Hematol Oncol,2017

2. Targeting CD47 and autophagy elicited enhanced antitumor effects in non–small cell lung cancer;Zhang;Cancer Immunol Res,2017

3. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer;Matlung;Immunol Rev,2017

4. Cancer immunotherapy targeting the CD47/SIRPα axis;Weiskopf;Eur J Cancer,2017

5. SIRPα-CD47 immune checkpoint blockade in anticancer therapy;Veillette;Trends Immunol,2018

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule innate immune modulators in cancer therapy;Frontiers in Immunology;2024-09-10

2. Preclinical testing of RRx-001 in mouse models of experimental endometriosis reveals promising therapeutic impacts;2024-08-12

3. Environmentally responsive hydrogel promotes vascular normalization to enhance STING anti-tumor immunity;Journal of Controlled Release;2024-08

4. Unraveling the role of NLRP3 inflammasome in allergic inflammation: implications for novel therapies;Frontiers in Immunology;2024-07-26

5. Development of small molecule drugs targeting immune checkpoints;Cancer Biology & Medicine;2024-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3